MetaADEDB 2.0 @ LMMD
Tamsulosin
(ZZIZZTHXZRDOFM-XFULWGLBSA-N)
Structure
SMILES
CCOc1ccccc1OCCN[C@@H](Cc1ccc(c(c1)S(=O)(=O)N)OC)C.Cl
Molecular Formula:
C20H29ClN2O5S
Molecular Weight:
444.973
Log P:
5.3149
Hydrogen Bond Acceptor:
7
Hydrogen Bond Donor:
3
TPSA:
108.26
CAS Number(s):
106463-17-6
Synonym(s)
1.
Tamsulosin
2.
5-(2-((2-(2-Ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzenesulfonamide
3.
Flomax
4.
LY 253352
5.
LY-253352
6.
Tamsulosin Hydrochloride
7.
YM 617
8.
YM-617
External Link(s)
MeSHD000077409
PubChem Compound5362376
25137847
ChEBI9399
CHEMBLCHEMBL1200914
KEGGdr:D01024
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Drug ineffectiveFAERS: 584
Canada Vigilance: 31
Canada Vigilance
US FAERS
2DizzinessFAERS: 373
Canada Vigilance: 10
Canada Vigilance
US FAERS
3NocturiaFAERS: 157US FAERS
4Procedural complicationFAERS: 132US FAERS
5SyncopeFAERS: 103
Canada Vigilance: 4
Canada Vigilance
US FAERS
6DysuriaFAERS: 90
Canada Vigilance: 1
Canada Vigilance
US FAERS
7HypotensionFAERS: 90US FAERS
8HeadacheFAERS: 87
Canada Vigilance: 2
Canada Vigilance
US FAERS
9CataractFAERS: 86US FAERS
10FatigueFAERS: 79
Canada Vigilance: 1
Canada Vigilance
US FAERS
11Semen volume decreasedFAERS: 74US FAERS
12Product substitution issueFAERS: 73
Canada Vigilance: 1
Canada Vigilance
US FAERS
13Cataract operation complicationFAERS: 69US FAERS
14Floppy iris syndromeFAERS: 64
Canada Vigilance: 19
Canada Vigilance
US FAERS
15Urinary RetentionFAERS: 61
Canada Vigilance: 2
Canada Vigilance
US FAERS
16Erectile dysfunctionFAERS: 60
Canada Vigilance: 1
Canada Vigilance
US FAERS
17NauseaFAERS: 59
Canada Vigilance: 5
Canada Vigilance
US FAERS
18Back PainFAERS: 57
Canada Vigilance: 1
Canada Vigilance
US FAERS
19PruritusFAERS: 56
Canada Vigilance: 2
Canada Vigilance
US FAERS
20AstheniaFAERS: 49
Canada Vigilance: 1
Canada Vigilance
US FAERS
21PainFAERS: 48
Canada Vigilance: 1
Canada Vigilance
US FAERS
22Retrograde ejaculationFAERS: 48US FAERS
23Urinary IncontinenceFAERS: 47US FAERS
24IridoceleFAERS: 45US FAERS
25SomnolenceFAERS: 43US FAERS
26Feeling abnormalFAERS: 38US FAERS
27Middle insomniaFAERS: 37US FAERS
28Urine flow decreasedFAERS: 36US FAERS
29UrticariaFAERS: 33
Canada Vigilance: 1
Canada Vigilance
US FAERS
30VertigoFAERS: 33US FAERS
31Abdominal discomfortFAERS: 30
Canada Vigilance: 1
Canada Vigilance
US FAERS
32ConstipationFAERS: 30
Canada Vigilance: 1
Canada Vigilance
US FAERS
33Abdominal PainFAERS: 27
Canada Vigilance: 1
Canada Vigilance
US FAERS
34PalpitationsFAERS: 27US FAERS
35MalaiseFAERS: 26US FAERS
36Sexual DysfunctionFAERS: 24US FAERS
37HypersensitivityFAERS: 23
Canada Vigilance: 1
Canada Vigilance
US FAERS
38TremorFAERS: 23US FAERS
39Cataract operationFAERS: 22US FAERS
40Cerebrovascular accidentFAERS: 22US FAERS
41Chest PainFAERS: 22
Canada Vigilance: 3
Canada Vigilance
US FAERS
42PresyncopeFAERS: 21US FAERS
43TachycardiaFAERS: 21US FAERS
44Unevaluable eventFAERS: 21US FAERS
45Medication ErrorFAERS: 20US FAERS
46PriapismFAERS: 20US FAERS
47Urinary hesitationFAERS: 20US FAERS
48BlindnessFAERS: 19US FAERS
49AnxietyFAERS: 18
Canada Vigilance: 2
Canada Vigilance
US FAERS
50ArthralgiaFAERS: 18
Canada Vigilance: 1
Canada Vigilance
US FAERS
51Residual urineFAERS: 18US FAERS
52Eye operation complicationFAERS: 17US FAERS
53TinnitusFAERS: 16US FAERS
54VomitingFAERS: 16US FAERS
55PneumoniaFAERS: 15US FAERS
56Weight decreasedFAERS: 15US FAERS
57Adverse eventFAERS: 14US FAERS
58Benign Prostatic HyperplasiaFAERS: 14US FAERS
59Chest discomfortFAERS: 14US FAERS
60EpistaxisFAERS: 14US FAERS
61Product quality issueFAERS: 14
Canada Vigilance: 1
Canada Vigilance
US FAERS
62ErythemaFAERS: 13US FAERS
63Inappropriate schedule of drug administrationFAERS: 13US FAERS
64MyalgiaFAERS: 12US FAERS
65Oropharyngeal painFAERS: 12US FAERS
66Visual disturbanceFAERS: 12US FAERS
67AngioedemaFAERS: 11US FAERS
68Blood urine presentFAERS: 11
Canada Vigilance: 1
Canada Vigilance
US FAERS
69Myocardial InfarctionFAERS: 11
Canada Vigilance: 1
Canada Vigilance
US FAERS
70OverdoseFAERS: 11US FAERS
71Post procedural complicationFAERS: 11US FAERS
72Visual ImpairmentFAERS: 11US FAERS
73Blood glucose increasedFAERS: 10US FAERS
74DisorientationFAERS: 10US FAERS
75IncontinenceFAERS: 10US FAERS
76LethargyFAERS: 10US FAERS
77Throat cancerFAERS: 10US FAERS
78Urinary tract infectionFAERS: 10US FAERS
79Wrong technique in product usage processFAERS: 10US FAERS
80AmnesiaFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
81Atrial FibrillationFAERS: 9US FAERS
82Erection increasedFAERS: 9US FAERS
83Lip swellingFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
84NephrolithiasisFAERS: 9US FAERS
85RhinitisFAERS: 9US FAERS
86ShockFAERS: 9US FAERS
87BradycardiaFAERS: 8US FAERS
88ChillsFAERS: 8US FAERS
89DementiaFAERS: 8US FAERS
90Intentional product misuseFAERS: 8US FAERS
91MonoplegiaFAERS: 8US FAERS
92Product use issueFAERS: 8US FAERS
93Skin lacerationFAERS: 8US FAERS
94ToothacheFAERS: 8US FAERS
95AlopeciaFAERS: 7US FAERS
96Anaphylactic shockFAERS: 7US FAERS
97Angina PectorisFAERS: 7US FAERS
98AnorexiaFAERS: 7US FAERS
99AnorgasmiaFAERS: 7US FAERS
100AsthmaFAERS: 7US FAERS
101Burning sensationFAERS: 7US FAERS
102Cold sweatFAERS: 7US FAERS
103CystitisFAERS: 7US FAERS
104DysarthriaFAERS: 7US FAERS
105DyspepsiaFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
106Eye painFAERS: 7US FAERS
107General physical health deteriorationFAERS: 7US FAERS
108Incorrect dose administeredFAERS: 7US FAERS
109Macular degenerationFAERS: 7US FAERS
110Nasal discomfortFAERS: 7US FAERS
111Retinal DetachmentFAERS: 7US FAERS
112Accidental overdoseFAERS: 6US FAERS
113Bladder spasmFAERS: 6US FAERS
114DiscomfortFAERS: 6US FAERS
115Drug dispensing errorFAERS: 6US FAERS
116DysgeusiaFAERS: 6US FAERS
117Intervertebral disc injuryFAERS: 6US FAERS
118Memory impairmentFAERS: 6US FAERS
119Musculoskeletal discomfortFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
120Myasthenia GravisFAERS: 6US FAERS
121NasopharyngitisFAERS: 6US FAERS
122WheezingFAERS: 6US FAERS
123jaundiceFAERS: 6US FAERS
124Alanine Aminotransferase IncreasedFAERS: 5US FAERS
125AnuriaFAERS: 5US FAERS
126AphasiaFAERS: 5US FAERS
127ArthritisFAERS: 5US FAERS
128Aspartate Aminotransferase IncreasedFAERS: 5US FAERS
129BedriddenFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
130Breast tendernessFAERS: 5US FAERS
131Cerebral InfarctionFAERS: 5US FAERS
132ChromaturiaFAERS: 5US FAERS
133Corneal degenerationFAERS: 5US FAERS
134DehydrationFAERS: 5US FAERS
135Depressed Level of ConsciousnessFAERS: 5US FAERS
136DysphoniaFAERS: 5US FAERS
137EnuresisFAERS: 5US FAERS
138FlatulenceFAERS: 5US FAERS
139Head discomfortFAERS: 5US FAERS
140Incorrect route of drug administrationFAERS: 5US FAERS
141Megakaryocytes increasedFAERS: 5US FAERS
142Musculoskeletal PainFAERS: 5US FAERS
143PallorFAERS: 5US FAERS
144Pharmaceutical product complaintFAERS: 5US FAERS
145SepsisFAERS: 5US FAERS
146SinusitisFAERS: 5US FAERS
147SwellingFAERS: 5US FAERS
148ThirstFAERS: 5US FAERS
149Activities of daily living impairedFAERS: 4US FAERS
150Altered state of consciousnessFAERS: 4US FAERS
151Amaurosis FugaxFAERS: 4US FAERS
152Bladder NeoplasmFAERS: 4US FAERS
153Bladder painFAERS: 4US FAERS
154Blood glucose decreasedFAERS: 4US FAERS
155Bone painFAERS: 4US FAERS
156Choroidal DetachmentFAERS: 4US FAERS
157Diabetes MellitusFAERS: 4US FAERS
158DiplopiaFAERS: 4US FAERS
159Disease recurrenceFAERS: 4US FAERS
160Drug administration errorFAERS: 4US FAERS
161Ear discomfortFAERS: 4US FAERS
162Feeling jitteryFAERS: 4US FAERS
163GlaucomaFAERS: 4US FAERS
164HypersomniaFAERS: 4US FAERS
165Impaired work abilityFAERS: 4US FAERS
166Male Orgasmic DisorderFAERS: 4US FAERS
167Medication residueFAERS: 4US FAERS
168Neck PainFAERS: 4US FAERS
169Night sweatsFAERS: 4US FAERS
170Nipple painFAERS: 4US FAERS
171Pelvic PainFAERS: 4US FAERS
172PolyuriaFAERS: 4US FAERS
173Product physical issueFAERS: 4US FAERS
174Product size issueFAERS: 4US FAERS
175Product use complaintFAERS: 4US FAERS
176Product use in unapproved indicationFAERS: 4US FAERS
177Productive CoughFAERS: 4US FAERS
178Pupillary light reflex tests abnormalFAERS: 4US FAERS
179Skin irritationFAERS: 4US FAERS
180Sperm count decreasedFAERS: 4US FAERS
181Spontaneous penile erectionFAERS: 4US FAERS
182Therapeutic response unexpectedFAERS: 4US FAERS
183Therapeutic response unexpected with drug substitutionFAERS: 4US FAERS
184Therapy non-responderFAERS: 4US FAERS
185Vitreous lossFAERS: 4US FAERS
186Wrong technique in drug usage processFAERS: 4US FAERS
187AbasiaFAERS: 3US FAERS
188AngerFAERS: 3US FAERS
189Aortic AneurysmFAERS: 3US FAERS
190ApathyFAERS: 3US FAERS
191Blood creatine phosphokinase increasedFAERS: 3US FAERS
192Blood creatinine increasedFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
193Cardiac TamponadeFAERS: 3US FAERS
194Cerebral disorderFAERS: 3US FAERS
195ChokingFAERS: 3US FAERS
196DeafnessFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
197DeliriumFAERS: 3US FAERS
198Drug DependenceFAERS: 3US FAERS
199Drug dose omissionFAERS: 3US FAERS
200Drug ineffective for unapproved indicationFAERS: 3US FAERS
201Drug toxicityFAERS: 3US FAERS
202FlushingFAERS: 3US FAERS
203FractureFAERS: 3US FAERS
204Gastric ulcerFAERS: 3US FAERS
205Gastrointestinal candidiasisFAERS: 3US FAERS
206GastrostomyFAERS: 3US FAERS
207Genital rashFAERS: 3US FAERS
208Gluten sensitivityFAERS: 3US FAERS
209HepatitisFAERS: 3US FAERS
210HerniaFAERS: 3US FAERS
211HydronephrosisFAERS: 3US FAERS
212HypokinesiaFAERS: 3US FAERS
213HypophagiaFAERS: 3US FAERS
214Incision site infectionFAERS: 3US FAERS
215InflammationFAERS: 3US FAERS
216Intentional drug misuseFAERS: 3US FAERS
217Joint stiffnessFAERS: 3US FAERS
218Joint swellingFAERS: 3US FAERS
219Limb discomfortFAERS: 3US FAERS
220LymphadenopathyFAERS: 3US FAERS
221MalabsorptionFAERS: 3US FAERS
222Muscle tightnessFAERS: 3US FAERS
223NervousnessFAERS: 3US FAERS
224OsteoporosisFAERS: 3US FAERS
225PancytopeniaFAERS: 3US FAERS
226ParanoiaFAERS: 3US FAERS
227Pericardial effusionFAERS: 3US FAERS
228PneumothoraxFAERS: 3US FAERS
229Prostatic specific antigen decreasedFAERS: 3US FAERS
230Pulmonary congestionFAERS: 3US FAERS
231Rash erythematousFAERS: 3US FAERS
232Semen analysis abnormalFAERS: 3US FAERS
233Sinus headacheFAERS: 3US FAERS
234Squamous cell carcinoma of skinFAERS: 3US FAERS
235Stevens-Johnson SyndromeFAERS: 3US FAERS
236StomatitisFAERS: 3US FAERS
237StressFAERS: 3US FAERS
238Surgical failureFAERS: 3US FAERS
239Throat irritationFAERS: 3US FAERS
240Vitreous floatersFAERS: 3US FAERS
241muscle injuryFAERS: 3US FAERS
242treatment failureFAERS: 3US FAERS
243Accidental drug intake by childFAERS: 2US FAERS
244AcneFAERS: 2US FAERS
245Acute myocardial infarctionFAERS: 2US FAERS
246Acute respiratory failureFAERS: 2US FAERS
247AgeusiaFAERS: 2US FAERS
248AmblyopiaFAERS: 2US FAERS
249Anaphylactoid ReactionFAERS: 2US FAERS
250Angle Closure GlaucomaFAERS: 2US FAERS
251Ankle FractureFAERS: 2US FAERS
252AnosmiaFAERS: 2US FAERS
253Blood PressureFAERS: 2US FAERS
254Blood lactate dehydrogenase increasedFAERS: 2US FAERS
255Blood testosterone decreasedFAERS: 2US FAERS
256Cardiac ArrestFAERS: 2US FAERS
257Cardiac FlutterFAERS: 2US FAERS
258Circumstance or information capable of leading to medication errorFAERS: 2US FAERS
259CryingFAERS: 2US FAERS
260DacryocystitisFAERS: 2US FAERS
261Dacryostenosis acquiredFAERS: 2US FAERS
262Depressed moodFAERS: 2US FAERS
263DermatitisFAERS: 2US FAERS
264Device occlusionFAERS: 2US FAERS
265Drug ToleranceFAERS: 2US FAERS
266Drug effect incompleteFAERS: 2US FAERS
267Drug prescribing errorFAERS: 2US FAERS
268Dry skinFAERS: 2US FAERS
269EcchymosisFAERS: 2US FAERS
270EczemaFAERS: 2US FAERS
271Emotional disorderFAERS: 2US FAERS
272EructationFAERS: 2US FAERS
273Eye inflammationFAERS: 2US FAERS
274Eye irritationFAERS: 2US FAERS
275Feeling ColdFAERS: 2US FAERS
276Foreign body traumaFAERS: 2US FAERS
277HemiparesisFAERS: 2US FAERS
278Hormone level abnormalFAERS: 2US FAERS
279Hypotonic urinary bladderFAERS: 2US FAERS
280IleusFAERS: 2US FAERS
281Impaired driving abilityFAERS: 2US FAERS
282IncoherentFAERS: 2US FAERS
283InfectionFAERS: 2US FAERS
284InfluenzaFAERS: 2US FAERS
285Intestinal ObstructionFAERS: 2US FAERS
286Iris injuryFAERS: 2US FAERS
287Joint InstabilityFAERS: 2US FAERS
288LabyrinthitisFAERS: 2US FAERS
289LacerationFAERS: 2US FAERS
290Leukocytoclastic vasculitisFAERS: 2US FAERS
291LeukocytosisFAERS: 2US FAERS
292Lip and/or oral cavity cancerFAERS: 2US FAERS
293Loss of bladder sensationFAERS: 2US FAERS
294Malabsorption from administration siteFAERS: 2US FAERS
295Malignant neoplasm progressionFAERS: 2US FAERS
296Medication residue presentFAERS: 2US FAERS
297Mental status changesFAERS: 2US FAERS
298Musculoskeletal chest painFAERS: 2US FAERS
299Musculoskeletal stiffnessFAERS: 2US FAERS
300MydriasisFAERS: 2US FAERS
301MyoglobinuriaFAERS: 2US FAERS
302Neuroleptic Malignant SyndromeFAERS: 2US FAERS
303Oral painFAERS: 2US FAERS
304Pancreatic carcinomaFAERS: 2US FAERS
305Peripheral swellingFAERS: 2US FAERS
306Pharyngolaryngeal PainFAERS: 2US FAERS
307Posterior capsule ruptureFAERS: 2US FAERS
308Pre-existing condition improvedFAERS: 2US FAERS
309Product difficult to swallowFAERS: 2US FAERS
310Prostate cancer recurrentFAERS: 2US FAERS
311Prostate examination abnormalFAERS: 2US FAERS
312Pseudoexfoliation of lens capsuleFAERS: 2US FAERS
313Pulmonary EmbolismFAERS: 2US FAERS
314Pupillary deformityFAERS: 2US FAERS
315Renal painFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
316Respiratory distressFAERS: 2US FAERS
317Rheumatoid ArthritisFAERS: 2US FAERS
318Sensation of blood flowFAERS: 2US FAERS
319Septic ShockFAERS: 2US FAERS
320Skin reactionFAERS: 2US FAERS
321Skin tightnessFAERS: 2US FAERS
322Sleep disorder due to general medical condition, insomnia typeFAERS: 2US FAERS
323SneezingFAERS: 2US FAERS
324Spermatozoa abnormalFAERS: 2US FAERS
325Spinal column stenosisFAERS: 2US FAERS
326StridorFAERS: 2US FAERS
327StuporFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
328Suicide attemptFAERS: 2US FAERS
329Tension HeadacheFAERS: 2US FAERS
330Terminal dribblingFAERS: 2US FAERS
331ThrombosisFAERS: 2US FAERS
332Urinary tract obstructionFAERS: 2US FAERS
333VIIth nerve paralysisFAERS: 2US FAERS
334Wrong drug administeredFAERS: 2US FAERS
335X-ray abnormalFAERS: 2US FAERS
336insulinomaFAERS: 2US FAERS
337Aase syndromeFAERS: 1US FAERS
338Abdominal InfectionFAERS: 1US FAERS
339Abdominal rigidityFAERS: 1US FAERS
340Accidental exposureFAERS: 1US FAERS
341AgitationFAERS: 1US FAERS
342Alcohol poisoningFAERS: 1US FAERS
343Altered visual depth perceptionFAERS: 1US FAERS
344Amyotrophic Lateral SclerosisFAERS: 1US FAERS
345Anal sphincter atonyFAERS: 1US FAERS
346AphagiaFAERS: 1US FAERS
347AphoniaFAERS: 1US FAERS
348Arterial therapeutic procedureFAERS: 1US FAERS
349ArthropathyFAERS: 1US FAERS
350AspermiaFAERS: 1US FAERS
351AstigmatismFAERS: 1US FAERS
352Atrial FlutterFAERS: 1US FAERS
353AzoospermiaFAERS: 1US FAERS
354Bacterial testFAERS: 1US FAERS
355Bladder stenosisFAERS: 1US FAERS
356Bladder transitional cell carcinoma metastaticFAERS: 1US FAERS
357BlepharitisFAERS: 1US FAERS
358Blood alkaline phosphatase increasedFAERS: 1US FAERS
359Blood potassium increasedFAERS: 1US FAERS
360Blood pressure fluctuationFAERS: 1US FAERS
361Blood testosterone free decreasedFAERS: 1US FAERS
362Bronchial ObstructionFAERS: 1US FAERS
363BronchitisFAERS: 1US FAERS
364BronchopneumoniaFAERS: 1US FAERS
365Bronchopulmonary AspergillosisFAERS: 1US FAERS
366CarcinomaFAERS: 1US FAERS
367Cardiovascular insufficiencyFAERS: 1US FAERS
368Carpal Tunnel SyndromeFAERS: 1US FAERS
369Catheter managementFAERS: 1US FAERS
370Cerebral circulatory failureFAERS: 1US FAERS
371Choking sensationFAERS: 1US FAERS
372CholangitisFAERS: 1US FAERS
373CholelithiasisFAERS: 1US FAERS
374Complication associated with deviceFAERS: 1US FAERS
375Corneal OpacityFAERS: 1US FAERS
376CyanosisFAERS: 1US FAERS
377Cystitis escherichiaFAERS: 1US FAERS
378CystFAERS: 1US FAERS
379Deep Vein ThrombosisFAERS: 1US FAERS
380DeformityFAERS: 1US FAERS
381DependenceFAERS: 1US FAERS
382DiverticulitisFAERS: 1US FAERS
383DroolingFAERS: 1US FAERS
384DrowningFAERS: 1US FAERS
385Drug administered to patient of inappropriate ageFAERS: 1US FAERS
386Drug delivery system malfunctionFAERS: 1US FAERS
387Drug dispensed to wrong patientFAERS: 1US FAERS
388Drug effect delayedFAERS: 1US FAERS
389Drug effect variableFAERS: 1US FAERS
390Drug screen positiveFAERS: 1US FAERS
391Duodenal UlcerFAERS: 1US FAERS
392DyschromatopsiaFAERS: 1US FAERS
393Ear operation complicationFAERS: 1US FAERS
394Enamel anomalyFAERS: 1US FAERS
395Epigastric discomfortFAERS: 1US FAERS
396Erythema MultiformeFAERS: 1US FAERS
397Escherichia infectionFAERS: 1US FAERS
398Excessive masturbationFAERS: 1US FAERS
399ExophthalmosFAERS: 1US FAERS
400Exposure to toxic agentFAERS: 1US FAERS
401Expulsion of medicationFAERS: 1US FAERS
402Eye complication associated with deviceFAERS: 1US FAERS
403Facial PainFAERS: 1US FAERS
404False positive investigation resultFAERS: 1US FAERS
405Fear of fallingFAERS: 1US FAERS
406Feeding tube complicationFAERS: 1US FAERS
407FolliculitisFAERS: 1US FAERS
408FormicationFAERS: 1US FAERS
409Free prostate-specific antigen decreasedFAERS: 1US FAERS
410Gait inabilityFAERS: 1US FAERS
411GastrectomyFAERS: 1US FAERS
412Gastric FistulaFAERS: 1US FAERS
413General physical condition abnormalFAERS: 1US FAERS
414Genital burning sensationFAERS: 1US FAERS
415Genital dischargeFAERS: 1US FAERS
416Genital painFAERS: 1US FAERS
417Genital swellingFAERS: 1US FAERS
418GoutFAERS: 1US FAERS
419Guttate psoriasisFAERS: 1US FAERS
420Head BangingFAERS: 1US FAERS
421Hepatic EncephalopathyFAERS: 1US FAERS
422Hepatitis CFAERS: 1US FAERS
423HypogeusiaFAERS: 1US FAERS
424HyporeflexiaFAERS: 1US FAERS
425Iatrogenic injuryFAERS: 1US FAERS
426ImmobileFAERS: 1US FAERS
427Impaired quality of lifeFAERS: 1US FAERS
428ImpatienceFAERS: 1US FAERS
429Inappropriate release of product for distributionFAERS: 1US FAERS
430Increased upper airway secretionFAERS: 1US FAERS
431Intercepted drug dispensing errorFAERS: 1US FAERS
432Intermittent Explosive DisorderFAERS: 1US FAERS
433Intervertebral Disc DegenerationFAERS: 1US FAERS
434Intervertebral disc disorderFAERS: 1US FAERS
435Intestinal stoma complicationFAERS: 1US FAERS
436Intraocular lens dislocationFAERS: 1US FAERS
437IritisFAERS: 1US FAERS
438Irritable Bowel SyndromeFAERS: 1US FAERS
439Joint injuryFAERS: 1US FAERS
440Laser TherapyFAERS: 1US FAERS
441Left Ventricular HypertrophyFAERS: 1US FAERS
442Limb injuryFAERS: 1US FAERS
443Loose toothFAERS: 1US FAERS
444Loss of personal independence in daily activitiesFAERS: 1US FAERS
445Lymphomatoid PapulosisFAERS: 1US FAERS
446LymphomaFAERS: 1US FAERS
447MYELODYSPLASTIC SYNDROMEFAERS: 1US FAERS
448Macular fibrosisFAERS: 1US FAERS
449Male sexual dysfunctionFAERS: 1US FAERS
450Medical device complicationFAERS: 1US FAERS
451MenorrhagiaFAERS: 1US FAERS
452Migraine with AuraFAERS: 1US FAERS
453MonoparesisFAERS: 1US FAERS
454Mood swingsFAERS: 1US FAERS
455Multiple PregnancyFAERS: 1US FAERS
456Muscle FatigueFAERS: 1US FAERS
457NephrectomyFAERS: 1US FAERS
458Nerve injuryFAERS: 1US FAERS
459Neutrophil count decreasedFAERS: 1US FAERS
460No adverse eventFAERS: 1US FAERS
461Nonspecific reactionFAERS: 1US FAERS
462Nuchal RigidityFAERS: 1US FAERS
463Ocular HypertensionFAERS: 1US FAERS
464OliguriaFAERS: 1US FAERS
465OnychomycosisFAERS: 1US FAERS
466Opiates positiveFAERS: 1US FAERS
467OsteopeniaFAERS: 1US FAERS
468Painful ejaculationFAERS: 1US FAERS
469PancreatitisFAERS: 1US FAERS
470Panic DisorderFAERS: 1US FAERS
471PemphigusFAERS: 1US FAERS
472PericarditisFAERS: 1US FAERS
473Pharmaceutical product counterfeitFAERS: 1US FAERS
474Pharyngeal StenosisFAERS: 1US FAERS
475Pharyngeal erosionFAERS: 1US FAERS
476PhotophobiaFAERS: 1US FAERS
477PleurisyFAERS: 1US FAERS
478Polyarteritis NodosaFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
479PolyarthritisFAERS: 1US FAERS
480Poor quality drug administeredFAERS: 1US FAERS
481Poor quality product administeredFAERS: 1US FAERS
482Poor quality sleepFAERS: 1US FAERS
483Postoperative ileusFAERS: 1US FAERS
484Precancerous cells presentFAERS: 1US FAERS
485Premature EjaculationFAERS: 1US FAERS
486PresbyopiaFAERS: 1US FAERS
487Prescription drug used without a prescriptionFAERS: 1US FAERS
488Product administered to patient of inappropriate ageFAERS: 1US FAERS
489Product counterfeitFAERS: 1US FAERS
490Product dose omissionFAERS: 1US FAERS
491Product formulation issueFAERS: 1US FAERS
492Product measured potency issueFAERS: 1US FAERS
493Product residue presentFAERS: 1US FAERS
494Product used for unknown indicationFAERS: 1US FAERS
495ProstatectomyFAERS: 1US FAERS
496Prostatic painFAERS: 1US FAERS
497PsoriasisFAERS: 1US FAERS
498PurpuraFAERS: 1US FAERS
499QRS axis abnormalFAERS: 1US FAERS
500Radiation injuryFAERS: 1US FAERS
501Rectal ProlapseFAERS: 1US FAERS
502RegurgitationFAERS: 1US FAERS
503Respiratory DepressionFAERS: 1US FAERS
504Respiratory FailureFAERS: 1US FAERS
505Respiratory arrestFAERS: 1US FAERS
506Restless Legs SyndromeFAERS: 1US FAERS
507RestlessnessFAERS: 1US FAERS
508RetchingFAERS: 1US FAERS
509Retinal Vein OcclusionFAERS: 1US FAERS
510RhinalgiaFAERS: 1US FAERS
511RhonchiFAERS: 1US FAERS
512RosaceaFAERS: 1US FAERS
513Salmonella test positiveFAERS: 1US FAERS
514Semen volume abnormalFAERS: 1US FAERS
515Semen volume increasedFAERS: 1US FAERS
516Sinus bradycardiaFAERS: 1US FAERS
517Skeletal injuryFAERS: 1US FAERS
518Skin PapillomaFAERS: 1US FAERS
519Skin lesionFAERS: 1US FAERS
520Skin necrosisFAERS: 1US FAERS
521SluggishnessFAERS: 1US FAERS
522SnoringFAERS: 1US FAERS
523SomnambulismFAERS: 1US FAERS
524Sperm concentration decreasedFAERS: 1US FAERS
525Sperm count abnormalFAERS: 1US FAERS
526Spermatozoa morphology abnormalFAERS: 1US FAERS
527Squamous cell carcinoma of lungFAERS: 1US FAERS
528Sudden Visual LossFAERS: 1US FAERS
529Suppressed lactationFAERS: 1US FAERS
530Supraventricular tachycardiaFAERS: 1US FAERS
531Systemic lupus erythematosus rashFAERS: 1US FAERS
532TachyarrhythmiaFAERS: 1US FAERS
533TachyphylaxisFAERS: 1US FAERS
534TensionFAERS: 1US FAERS
535Testis discomfortFAERS: 1US FAERS
536Therapeutic product ineffectiveFAERS: 1US FAERS
537Therapeutic reaction time decreasedFAERS: 1US FAERS
538Therapeutic response changedFAERS: 1US FAERS
539Therapeutic response delayedFAERS: 1US FAERS
540Therapy cessationFAERS: 1US FAERS
541Thermal burnFAERS: 1US FAERS
542ThrombocytopeniaFAERS: 1US FAERS
543Toxicologic test abnormalFAERS: 1US FAERS
544Traumatic Brain InjuryFAERS: 1US FAERS
545Type III immune complex mediated reactionFAERS: 1US FAERS
546Upper airway obstructionFAERS: 1US FAERS
547Urethral ObstructionFAERS: 1US FAERS
548Urethral StenosisFAERS: 1US FAERS
549Urinary sediment presentFAERS: 1US FAERS
550Urine cannabinoids increasedFAERS: 1US FAERS
551Urine ketone bodyFAERS: 1US FAERS
552Urine output increasedFAERS: 1US FAERS
553VasculitisFAERS: 1US FAERS
554Venous thrombosis limbFAERS: 1US FAERS
555Ventricular arrhythmiaFAERS: 1US FAERS
556Ventricular hypertrophyFAERS: 1US FAERS
557VitrectomyFAERS: 1US FAERS
558Vitreous DetachmentFAERS: 1US FAERS
559Vitreous prolapseFAERS: 1US FAERS
560Vulvovaginal drynessFAERS: 1US FAERS
561cancer surgeryFAERS: 1US FAERS
562prostatitisFAERS: 1US FAERS
563Pharyngeal swellingCanada Vigilance: 2Canada Vigilance
564Product quality control issueCanada Vigilance: 1Canada Vigilance
565ProstatismCanada Vigilance: 1Canada Vigilance
566Soft tissue inflammationCanada Vigilance: 1Canada Vigilance
567Therapeutic product cross-reactivityCanada Vigilance: 1Canada Vigilance
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.